Literature DB >> 7386306

The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels.

G M Milne, T M Twomey.   

Abstract

In animal antinociceptive tests responsive to non-steroidal anti-inflammatory drugs (NSAID), piroxicam is an extremely potent and effective analgetic at doses of 1--2 mg/kg p.o. In mice the plasma half-life and duration of analgetic action is short (t 1/2 = 1.7 h), unlike man, wherein piroxicam exhibits an exceptionally long duration of action (half-life 40--45 h). An excellent correlation is observed between plasma levels and analgetic activity in the writhing test in mice suggesting that piroxicam will exhibit potent and long-lasting analgetic activity in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7386306     DOI: 10.1007/bf02024176

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  NOCICEPTIVE THRESHOLDS AS AFFECTED BY PARENTERAL ADMINISTRATION OF IRRITANTS AND OF VARIOUS ANTINOCICEPTIVE DRUGS.

Authors:  C A WINTER; L FLATAKER
Journal:  J Pharmacol Exp Ther       Date:  1965-06       Impact factor: 4.030

2.  A method for measurement of analgesic activity on inflamed tissue.

Authors:  L O RANDALL; J J SELITTO
Journal:  Arch Int Pharmacodyn Ther       Date:  1957-09-01

3.  A comparative evaluation of marketed analgesic drugs.

Authors:  C G Moertel; D L Ahmann; W F Taylor; N Schwartau
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

4.  Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor.

Authors:  S S Tenen
Journal:  Psychopharmacologia       Date:  1968

5.  Piroxicam, a novel anti-inflammatory agent.

Authors:  E H Wiseman; Y H Chang; J G Lombardino
Journal:  Arzneimittelforschung       Date:  1976

6.  Potent anti-inflammatory N-heterocyclic 3-carboxamides of 4-hydroxy-2-methyl-2H-1,2-benzothiazine 1,1-dioxide.

Authors:  J G Lombardino; E H Wiseman; J Chiaini
Journal:  J Med Chem       Date:  1973-05       Impact factor: 7.446

7.  Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies.

Authors:  D C Hobbs; T M Twomey
Journal:  J Clin Pharmacol       Date:  1979 May-Jun       Impact factor: 3.126

  7 in total
  8 in total

1.  Tenidap, a structurally novel drug for the treatment of arthritis: antiinflammatory and analgesic properties.

Authors:  P F Moore; D L Larson; I G Otterness; A Weissman; S B Kadin; F J Sweeney; J D Eskra; A Nagahisa; M Sakakibara; T J Carty
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

2.  The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure.

Authors:  J L Stock; K Shinjo; J Burkhardt; M Roach; K Taniguchi; T Ishikawa; H S Kim; P J Flannery; T M Coffman; J D McNeish; L P Audoly
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 3.  The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.

Authors:  B Dubinsky; S Gebre-Mariam; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1987-02

Review 4.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

5.  Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam.

Authors:  T J Carty; A Marfat; P F Moore; F C Falkner; T M Twomey; A Weissman
Journal:  Agents Actions       Date:  1993-07

Review 6.  Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states.

Authors:  S P Clissold; R Beresford
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

Review 7.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

8.  The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1.

Authors:  J L Teeling; C Cunningham; T A Newman; V H Perry
Journal:  Brain Behav Immun       Date:  2009-12-04       Impact factor: 7.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.